Yes, amoxicillin is appropriate for treating cellulitis caused by a penicillin-susceptible organism in patients without penicillin allergy.
Amoxicillin is explicitly listed as a suitable first-line oral antibiotic for typical cellulitis by the Infectious Diseases Society of America (IDSA) 2014 guidelines 1111. The FDA label confirms amoxicillin is indicated for skin and skin structure infections 2.
Rationale and Evidence
The IDSA guidelines are unequivocal: for typical cellulitis, therapy should include an antibiotic active against streptococci, and amoxicillin is specifically named among suitable antibiotics including penicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin 1111. Since you've confirmed the organism is penicillin-susceptible and the patient has no penicillin allergy, amoxicillin provides appropriate coverage.
Key Clinical Points:
Target Pathogen Coverage:
- Typical cellulitis is primarily caused by β-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus 3
- Amoxicillin provides excellent streptococcal coverage, which is the primary concern in non-purulent cellulitis
- A prospective study demonstrated that β-lactams like cefazolin or oxacillin were successful in 96% of cellulitis patients, confirming MRSA is uncommon in typical cellulitis 11
Treatment Duration:
- For uncomplicated cellulitis, a 5-day course is as effective as a 10-day course if clinical improvement occurs by day 5 111
- Treatment should continue for a minimum of 48-72 hours beyond symptom resolution 2
When NOT to Use Amoxicillin Alone:
- Cellulitis with purulent drainage, penetrating trauma (especially IV drug use), or concurrent MRSA infection elsewhere requires MRSA coverage 11
- In these cases, add coverage with either clindamycin alone OR combine amoxicillin with SMX-TMP or doxycycline 11
Clinical Outcomes Data:
Recent research supports this approach. A 2019 study demonstrated that adherence to guidelines recommending amoxicillin (with or without clavulanate), clindamycin, or pristinamycin was associated with favorable outcomes (poor outcome rate 6.3% vs 12.7% with non-adherent therapy, p=0.007) 4. Another 2019 study found amoxicillin-clavulanate was linked with the shortest hospital stays 5.
Important Caveats:
- Do NOT use amoxicillin in patients with mononucleosis - a high percentage develop erythematous rash 2
- Amoxicillin is contraindicated in patients with serious hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome) to β-lactams 22
- For patients with severe renal impairment (GFR <30 mL/min), dose adjustment is required 2
Dosing:
- Standard adult dose: 500 mg every 8 hours or 875 mg every 12 hours (depending on severity) 2
- Patients with GFR <30 mL/min should NOT receive the 875 mg dose 2
The bottom line: Amoxicillin is guideline-concordant, effective, and appropriate for this clinical scenario 111134.